MYLAN 2045 MYLAN 2045 (Tacrolimus 0.5 mg)

Pill imprint MYLAN 2045 MYLAN 2045 has been identified as Tacrolimus 0.5 mg.

Tacrolimus is used in the treatment of organ transplant, rejection reversal; organ transplant, rejection prophylaxis; graft-versus-host disease; crohn's disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 0.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MYLAN 2045 MYLAN 2045

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.